These discrepancies could be explained by different types of cancer cell models used in these studies: HeLa vs. U2OS cells, implying that biological effects of Smurf2 should be very carefully interpreted taking into account cellular context, genetic make-up, and experimental settings. This evidence concerns the gene SMURF2 and cancer.